Frontier Space Technologies Secures £116k to Advance In-Orbit Manufacturing

Frontier Space Technologies Ltd, a Nottingham-based innovator in the burgeoning space technology sector, has successfully closed a funding round, raising an estimated £116k. This early-stage investment values the company at an estimated post-money valuation of £914.3k, marking a significant step for the firm focused on democratising access to space for scientific research and commercial ventures.

Founded on 9 March 2021, Frontier Space Technologies is at the forefront of providing customizable, autonomous, and miniaturized satellite laboratories. Their flagship product, SpaceLab, is designed to capture experimental data and facilitate in-orbit manufacturing of high-value bioproducts. The company primarily targets space researchers and the biopharma industry, addressing the challenge of limited and costly access to space for critical scientific and industrial applications. By offering accessible platforms for microgravity research and manufacturing, Frontier Space Technologies aims to unlock breakthroughs in biotechnology and space-based production. The company currently employs 9 individuals, reflecting its focused and specialised team.

The recent funding round, with an estimated size of £116k, saw its allotment date on 10 April 2026, and was officially filed on 1 May 2026. This pre-seed stage investment, valuing the company at just under £1 million post-money, positions Frontier Space Technologies for its initial growth phase. As a newly funded entity, there are no previous public funding rounds to compare this latest investment against.

This funding round for Frontier Space Technologies aligns with a period of increasing investment and strategic focus on the UK's space technology and deep tech sectors, particularly in areas like in-orbit manufacturing and space-based biotechnology. The UK has positioned itself as a significant player in the global space economy, aiming to become a leading European space exporter by 2030. The government has committed substantial resources, including £105 million to develop civil capabilities for in-orbit servicing and manufacturing (ISAM), an emerging market where the UK holds a strong competitive edge. The broader In-Orbit Servicing and Manufacturing (IOSM) market is projected to be worth almost £11 billion by 2031, with a £2.7 billion market opportunity for the UK.

Recent data indicates a robust funding environment for deep tech in the UK. In 2026, up to April, Deep Tech companies in the United Kingdom have collectively raised $5.44 billion across 60 rounds, representing a 123.01% rise in funding compared to the same period in 2025. Since 2019, UK deep tech startups have attracted $43.7 billion in venture capital, placing the UK third globally behind the United States and China. Deep tech now accounts for 31% of all UK VC funding, a threefold increase over the past decade.

Specifically within the space technology sector, UK companies have raised $40.9 million in equity funding across one round in 2026 until February, showing a 15.41% rise in funding compared to the same period in 2025. The UK is recognised as the most attractive destination for private investment in space after the US, with key investment areas including Earth observation, manufacturing, and satellite connectivity.

Several companies operating in similar niches have also recently secured significant investments. For instance, London-based BioOrbit raised £9.8 million in seed funding in May 2026 to advance its approach to manufacturing pharmaceutical drugs in space. The UK Space Agency has also supported early-stage projects, including a £250,000 feasibility study for BioOrbit to explore crystallising biologic drugs in space. Another notable example is Space Forge, which secured a record-breaking £22.6 million in Series A funding in May 2025, marking the largest Series A investment in UK space tech history. Furthermore, LinkGevity was awarded a UK Space Agency Grant in November 2025 to prepare its Anti-Necrotic therapeutic for deployment in space.

Frontier Space Technologies' successful funding round underscores the continued investor confidence in the UK's deep tech and space sectors, particularly in innovative applications that bridge space research with commercial biotechnology. This investment will enable the Nottingham-based company to further develop its miniaturized satellite laboratories and contribute to the UK's ambition to lead in the in-orbit manufacturing landscape.